• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Industrials·PL
Held by 3 Gurus
Share

Planet Labs PBC Stocks

$ 13.41Last Updated 23.10.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 4.56B

$ 13.41
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

Point72 Asset Management, L.P.

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Bridgewater Associates

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%-0.00%
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.0%+0.00%

Latest news

16.09.2026 08:00

The U.S. has confirmed the existence of space weapons for the first time. Which companies stand to benefit from this?

04.09.2026 15:50

Planet Labs soaring on second-quarter revenue and EBITDA beat

12.06.2026 14:47

Morning in New York: risk appetite returns

08.06.2026 16:01

New York Morning: Middle East back in the spotlight

30.05.2026 00:56

Space stocks sell off after Blue Origin rocket explosion and SpaceX valuation cut

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Planet Labs PBC is dedicated to the creation, deployment, and management of extensive satellite constellations. Its core mission is to provide frequent, worldwide geospatial data, which customers can access through a specialized online platform. The company's offerings include a proprietary, cloud-native technological solution, branded as "Open Geospatial Consortium," that meticulously processes and unifies imagery for temporal analysis and advanced data integration. Additionally, they furnish space-based equipment and complementary software systems. Planet Labs caters to a diverse clientele across sectors such as agriculture, cartography, forestry, and the finance and insurance industries, alongside federal, state, and municipal government bodies. The organization was established in 2010 and maintains its primary operational base in San Francisco, California.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA, overvalued on P/F

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of PL is 31.2 and suggests 133% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.10.2026 19:13

Data from clinical trials of an anti-hunger drug sent Aardvark's stock plummeting by 65%. What's next?

26.10.2026 18:59

Anthropic's IPO Prospectus Has Restored Faith in AI Stocks: The S&P 500 and Nasdaq Are Rising

26.10.2026 18:35

Unsteady Revenue Growth and 100 Pages of Risks: What Anthropic's IPO Prospectus Revealed

26.10.2026 18:31

Brazilian assets plummeted following the election shock. Which stocks do analysts still favor?

26.10.2026 18:10

Robert Half's stock has soared. Wall Street is betting on its "strong recovery"

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026